Jennison Associates LLC Burning Rock Biotech LTD Transaction History

Jennison Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$9.43 - $17.14 $5.35 Million - $9.73 Million	-567,783 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$17.37 - $27.92 $19.7 Million - $31.6 Million	-1,132,026 Reduced 66.6%	567,783 $10.2 Million
Q2 2021 Aug 12, 2021	SELL	$26.14 - $37.45 $6.18 Million - $8.85 Million	-236,269 Reduced 12.2%	1,699,809 $50.1 Million
Q1 2021 May 11, 2021	BUY	$23.5 - $39.58 $2.64 Million - $4.44 Million	112,255 Added 6.15%	1,936,078 $52.1 Million
Q4 2020 Feb 05, 2021	BUY	$22.55 - $30.87 $27.5 Million - $37.6 Million	1,218,712 Added 201.4%	1,823,823 $42.1 Million
Q3 2020 Nov 04, 2020	BUY	$19.07 - $29.61 $2.54 Million - $3.94 Million	133,065 Added 28.19%	605,111 $15.2 Million
Q2 2020 Aug 06, 2020	BUY	$23.21 - $31.43 $11 Million - $14.8 Million	472,046 New	472,046 $12.8 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.